Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Alzheimer's Disease Presenilin-1 Mutation Sensitizes Neurons to Impaired Autophagy Flux and Propofol Neurotoxicity: Role of Calcium Dysregulation.

Tytuł:
Alzheimer's Disease Presenilin-1 Mutation Sensitizes Neurons to Impaired Autophagy Flux and Propofol Neurotoxicity: Role of Calcium Dysregulation.
Autorzy:
Yang M; Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Anesthesiology, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
Wang Y; Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Anesthesiology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Liang G; Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Xu Z; Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Anesthesiology, Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, China.
Chu CT; Department of Pathology, Division of Neuropathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Wei H; Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Źródło:
Journal of Alzheimer's disease : JAD [J Alzheimers Dis] 2019; Vol. 67 (1), pp. 137-147.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Język:
English
Imprint Name(s):
Original Publication: Amsterdam ; Washington : IOS Press, c1998-
MeSH Terms:
Alzheimer Disease/*genetics
Anesthetics, Intravenous/*toxicity
Autophagy/*genetics
Calcium Metabolism Disorders/*genetics
Calcium Metabolism Disorders/*pathology
Neurons/*drug effects
Neurotoxicity Syndromes/*genetics
Neurotoxicity Syndromes/*pathology
Presenilin-1/*genetics
Propofol/*toxicity
Adenosine Triphosphatases/biosynthesis ; Animals ; Calcium Metabolism Disorders/metabolism ; Humans ; Neurotoxicity Syndromes/metabolism ; PC12 Cells ; Rats ; Ryanodine Receptor Calcium Release Channel/drug effects
References:
J Biol Chem. 2000 Jun 16;275(24):18195-200. (PMID: 10764737)
J Neurosci. 1997 Jun 1;17(11):4212-22. (PMID: 9151738)
Neurobiol Aging. 2008 Jul;29(7):1002-10. (PMID: 17346857)
PLoS One. 2012;7(12):e51431. (PMID: 23251531)
Biochim Biophys Acta. 2009 May;1787(5):335-44. (PMID: 19268425)
Cell Calcium. 2016 Aug;60(2):74-87. (PMID: 27157108)
Toxicol Appl Pharmacol. 2011 Feb 1;250(3):291-8. (PMID: 21059370)
PLoS One. 2011;6(11):e27019. (PMID: 22069482)
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:156-61. (PMID: 23721657)
Autophagy. 2015;11(8):1437-8. (PMID: 26156798)
Anesthesiology. 2008 Feb;108(2):251-60. (PMID: 18212570)
Anesthesiology. 2017 Sep;127(3):490-501. (PMID: 28614084)
J Neurosci. 2011 Jan 12;31(2):700-11. (PMID: 21228179)
Cell Rep. 2015 Sep 1;12(9):1430-44. (PMID: 26299959)
Neurobiol Dis. 2011 Jul;43(1):38-45. (PMID: 21296668)
J Biol Chem. 2000 Dec 8;275(49):38731-8. (PMID: 10940303)
Anesthesiology. 2013 Mar;118(3):537-49. (PMID: 23314167)
Ann N Y Acad Sci. 2007 Feb;1097:265-77. (PMID: 17413028)
Neural Plast. 2017;2017:9182748. (PMID: 29119024)
Neurosci Lett. 2012 May 16;516(2):274-9. (PMID: 22516463)
J Neurosci. 2007 Feb 7;27(6):1247-54. (PMID: 17287498)
J Neurosci. 2014 May 14;34(20):6910-23. (PMID: 24828645)
J Alzheimers Dis Parkinsonism. 2017 Aug;7(5):. (PMID: 29214114)
Sci Signal. 2010 Mar 23;3(114):ra22. (PMID: 20332427)
Nature. 2006 Jun 15;441(7095):880-4. (PMID: 16625205)
J Neurosci. 1998 Jun 15;18(12):4439-50. (PMID: 9614221)
J Pharmacol Exp Ther. 2010 Apr;333(1):14-22. (PMID: 20086058)
Antioxid Redox Signal. 2011 Apr 1;14(7):1275-88. (PMID: 20615073)
Anesthesiology. 2014 Sep;121(3):528-37. (PMID: 24878495)
Proc Natl Acad Sci U S A. 2013 Sep 10;110(37):14825-6. (PMID: 23995445)
Exp Biol Med (Maywood). 2016 Apr;241(8):854-62. (PMID: 26643865)
Nat Cell Biol. 2015 Mar;17(3):288-99. (PMID: 25720963)
Neurotoxicol Teratol. 2011 Sep-Oct;33(5):592-7. (PMID: 21708249)
Sci Rep. 2017 Sep 28;7(1):12378. (PMID: 28959036)
BMC Geriatr. 2011 Dec 14;11:83. (PMID: 22168260)
Br J Anaesth. 2014 Oct;113(4):695-707. (PMID: 24699520)
Eur J Neurosci. 2008 Mar;27(5):1119-30. (PMID: 18294209)
Neurobiol Aging. 2004 Nov-Dec;25(10):1263-72. (PMID: 15465622)
Neurotoxicol Teratol. 2017 Mar - Apr;60:59-62. (PMID: 27856359)
Brain Res. 2005 Mar 10;1037(1-2):139-47. (PMID: 15777762)
Anesth Analg. 2008 Feb;106(2):492-500, table of contents. (PMID: 18227305)
Nat Commun. 2014 Sep 05;5:4834. (PMID: 25189398)
Brain. 2011 Jan;134(Pt 1):258-77. (PMID: 21186265)
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2777-82. (PMID: 21285369)
J Cereb Blood Flow Metab. 2010 May;30(5):1017-30. (PMID: 20068576)
PLoS One. 2014 Jun 16;9(6):e99171. (PMID: 24932894)
Autophagy. 2015;11(7):1192-5. (PMID: 26043755)
Grant Information:
R01 AG026389 United States AG NIA NIH HHS; R01 AG061447 United States AG NIA NIH HHS; R01 GM084979 United States GM NIGMS NIH HHS
Contributed Indexing:
Keywords: Alzheimer’s disease; anesthesia; autophagy; calcium; presenilin
Substance Nomenclature:
0 (Anesthetics, Intravenous)
0 (PSEN1 protein, human)
0 (Presenilin-1)
0 (Ryanodine Receptor Calcium Release Channel)
EC 3.6.1.- (Adenosine Triphosphatases)
YI7VU623SF (Propofol)
Entry Date(s):
Date Created: 20190115 Date Completed: 20200302 Latest Revision: 20200309
Update Code:
20240104
PubMed Central ID:
PMC6367936
DOI:
10.3233/JAD-180858
PMID:
30636740
Czasopismo naukowe
Background: Disruption of intracellular Ca2+ homeostasis and associated autophagy dysfunction contribute to neuropathology in Alzheimer's disease (AD).
Objective: To study the effects of propofol on cell viability via its effects on intracellular Ca2+ homeostasis, and the impact of autophagy, in a neuronal model of presenilin-mutated familial AD (FAD).
Methods: We treated PC12 cells, stably transfected with either mutated presenilin-1 (L286V) or wild type (WT) controls, with propofol at different doses and durations, in the presence or absence of extracellular Ca2+, antagonists of inositol trisphosphate receptors (InsP3R, xestospongin C) and/or ryanodine receptors (RYR, dantrolene), or an inhibitor of autophagy flux (Bafilomycin). We determined cell viability, cytosolic Ca2+ concentrations ([Ca2+]c), vATPase protein expression, and lysosomal acidification.
Results: The propofol dose- and time-dependently decreased cell viability significantly more in L286V than WT cells, especially at the pharmacological dose (>50μM), and together with bafilomycin (40 nM). Clinically used concentrations of propofol (<20μM) tended to increase cell viability. Propofol significantly increased [Ca2+]c more in L286V than in WT cells, which was associated with decrease of vATPase expression and localization to the lysosome. Both toxicity and increased Ca2+ levels were ameliorated by inhibiting InsP3R/RYR. However, the combined inhibition of both receptors paradoxically increased [Ca2+]c, by inducing Ca2+ influx from the extracellular space, causing greater cytotoxicity.
Conclusion: Impairment in autophagy function acts to deteriorate cell death induced by propofol in FAD neuronal cells. Cell death is ameliorated by either RYR or InsP3R antagonists on their own, but not when both are co-administered.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies